{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:17:28Z","timestamp":1789802248336,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Eosinophilic gastrointestinal disorders, also known as eosinophilic gastroenteritis, are rare inflammatory conditions characterized by eosinophilic infiltration of different parts of the gastrointestinal tract, along with peripheral eosinophilia in most cases. Other known causes for gut eosinophilic infiltration must be excluded to confirm the diagnosis of eosinophilic gastroenteritis. Symptoms of the disorder depend on the affected gastrointestinal tract segment and depth of involvement. Treatment includes systemic glucocorticoids and\/or dietary therapy with an empiric elimination diet. Second line therapies include the leukotriene receptor antagonist montelukast, and other anti-allergy drugs such as mast cell stabilizers (including cromolyn and the H1-antihistamine ketotifen), suplatast tosilate which is a selective Th-2 cytokines (IL-4 and IL-5) inhibitor, and the monoclonal anti-IgE antibody omalizumab. We report a case of eosinophilic gastroenteritis who was successfully treated and achieved remission with montelukast as an initial monotherapy. Upon extensive literature review, this represents the second reported adult case of eosinophilic gastroenteritis who responds to montelukast alone as a first line therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 49-year-old female presented with recurrent abdominal pain, vomiting, diarrhea and unexplained eosinophilia. She was diagnosed with eosinophilic gastroenteritis and was successfully treated with montelukast monotherapy. After 7\u00a0days of therapy, the patient responded well and had complete resolution of her gastrointestinal symptoms and peripheral eosinophilia. Patient remained in remission on follow-up after 12\u00a0months. We reviewed the literature for leukotriene antagonist use in the treatment of eosinophilic gastroenteritis and included the cases treated with the leukotriene antagonist montelukast as an initial therapy or as a second line therapy for refractory disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Montelukast may be an effective treatment for eosinophilic gastroenteritis, either alone or in combination with systemic steroids or ketotifen. Our patient is the second reported adult case of eosinophilic gastroenteritis who responded to montelukast alone as a first line therapy. Further studies and clinical trials are required to confirm efficacy compared to standard therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-021-01854-x","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T10:03:12Z","timestamp":1625738592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-9535","authenticated-orcid":false,"given":"Emran A.","family":"El-Alali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Abukhiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik Z.","family":"Alhmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"1854_CR1","doi-asserted-by":"publisher","unstructured":"Alhmoud T, Hanson JA, Parasher G. Eosinophilic gastroenteritis: an underdiagnosed condition. Dig Dis Sci. 2016;61. https:\/\/doi.org\/10.1007\/s10620-016-4203-5.","DOI":"10.1007\/s10620-016-4203-5"},{"key":"1854_CR2","doi-asserted-by":"publisher","unstructured":"Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol. 2017;15. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.050.","DOI":"10.1016\/j.cgh.2017.05.050"},{"key":"1854_CR3","doi-asserted-by":"publisher","unstructured":"Jensen ET, Martin CF, Kappelman MD. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database. J Pediatr Gastroenterol Nutr. 2016;62. https:\/\/doi.org\/10.1097\/MPG.0000000000000865.","DOI":"10.1097\/MPG.0000000000000865"},{"key":"1854_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.14309\/ajg.0000000000000228","volume":"114","author":"RD Pesek","year":"2019","unstructured":"Pesek RD, Reed CC, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, et al. Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis and colitis based on 10 year data across a multi-center consortium. Am J Gastroenterol. 2019;114:984.","journal-title":"Am J Gastroenterol"},{"key":"1854_CR5","doi-asserted-by":"publisher","unstructured":"Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990;31. https:\/\/doi.org\/10.1136\/gut.31.1.54.","DOI":"10.1136\/gut.31.1.54"},{"key":"1854_CR6","doi-asserted-by":"publisher","unstructured":"Ko HM, Morotti RA, Yershov O, Chehade M. Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy. Am J Gastroenterol. 2014;109. https:\/\/doi.org\/10.1038\/ajg.2014.166.","DOI":"10.1038\/ajg.2014.166"},{"key":"1854_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4292\/wjgpt.v7.i4.513","volume":"7","author":"Antoine Abou Rached WEH","year":"2016","unstructured":"Antoine Abou Rached WEH. Eosinophilic gastroenteritis: approach to diagnosis and management. World J Gastrointest Pharmacol Ther. 2016;7:513.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"1854_CR8","unstructured":"Shih HM, Bair MJ, Chen HL, Lin IT. Eosinophilic Gastroenteritis: brief review. Acta Gastroenterol Belg. 2016;79. https:\/\/pubmed.ncbi.nlm.nih.gov\/27382945\/."},{"key":"1854_CR9","doi-asserted-by":"publisher","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15. https:\/\/doi.org\/10.1517\/14740338.2016.1140743.","DOI":"10.1517\/14740338.2016.1140743"},{"key":"1854_CR10","doi-asserted-by":"publisher","unstructured":"Straumann A, Simon HU. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy. 2004;59. https:\/\/doi.org\/10.1046\/j.1398-9995.2003.00382.x.","DOI":"10.1046\/j.1398-9995.2003.00382.x"},{"key":"1854_CR11","unstructured":"Wong GW, Lim KH, Wan WK, Low SC, Kong SC. Eosinophilic gastroenteritis: clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital. Med J Malaysia. 2015;70. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/26358020\/."},{"key":"1854_CR12","doi-asserted-by":"publisher","unstructured":"Tien FM, Wu JF, Jeng YM, Hsu HY, Ni YH, Chang MH, et al. Clinical features and treatment responses of children with eosinophilic gastroenteritis. Pediatr Neonatol. 2011;52. https:\/\/doi.org\/10.1016\/j.pedneo.2011.06.006.","DOI":"10.1016\/j.pedneo.2011.06.006"},{"key":"1854_CR13","doi-asserted-by":"publisher","unstructured":"C SK, Das RR, Balakrishnan CD, Balagurunathan K, Chaudhuri K. Malabsorption syndrome and leukotriene inhibitor. J Trop Pediatr. 2011;57. https:\/\/doi.org\/10.1093\/tropej\/fmq052.","DOI":"10.1093\/tropej\/fmq052"},{"key":"1854_CR14","doi-asserted-by":"publisher","unstructured":"Neustrom MR, Friesen C. Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol. 1999;104. https:\/\/doi.org\/10.1016\/s0091-6749(99)70404-5.","DOI":"10.1016\/s0091-6749(99)70404-5"},{"key":"1854_CR15","doi-asserted-by":"publisher","unstructured":"Hui CK, Hui NK. A prospective study on the prevalence, extent of disease and outcome of eosinophilic gastroenteritis in patients presenting with lower abdominal symptoms. Gut Liver. 2018;12. https:\/\/doi.org\/10.5009\/gnl17056.","DOI":"10.5009\/gnl17056"},{"key":"1854_CR16","doi-asserted-by":"publisher","unstructured":"Priyadarshni S, Surapaneni BK, Dave K, Kaplan S, Patel N. Upper gastrointestinal bleed in a young male- a rare presentation of eosinophilic gastroenteritis. Cureus. 2020;12. https:\/\/doi.org\/10.7759\/cureus.7059.","DOI":"10.7759\/cureus.7059"},{"key":"1854_CR17","doi-asserted-by":"publisher","unstructured":"Chen B, Yang Z, Lu H, Wei C, Wang F, Liu C. Eosinophilic gastroenteritis presenting as upper gastrointestinal hematoma and ulcers after endoscopic biopsy: A case report and literature review. Medicine . 2017;96. https:\/\/doi.org\/10.1097\/MD.0000000000008075.","DOI":"10.1097\/MD.0000000000008075"},{"key":"1854_CR18","doi-asserted-by":"publisher","unstructured":"Baek MS, Mok YM, Han WC, Kim YS. A patient with eosinophilic gastroenteritis presenting with acute pancreatitis and ascites. Gut Liver. 2014;8. https:\/\/doi.org\/10.5009\/gnl.2014.8.2.224.","DOI":"10.5009\/gnl.2014.8.2.224"},{"key":"1854_CR19","doi-asserted-by":"publisher","unstructured":"Mili\u0107 S, Poropat G, Mali\u0107 D, Stimac D. A case of postpartum eosinophilic gastroenteritis and review of the literature. Dig Dis. 2012;30. https:\/\/doi.org\/10.1159\/000336711.","DOI":"10.1159\/000336711"},{"key":"1854_CR20","doi-asserted-by":"crossref","unstructured":"Quack I, Sellin L, Buchner NJ, Theegarten D, Rump LC, Henning BF. Eosinophilic gastroenteritis in a young girl \u2013 long term remission under Montelukast. BMC Gastroenterol. 2005;5:24.","DOI":"10.1186\/1471-230X-5-24"},{"key":"1854_CR21","unstructured":"De Maeyer N, Kochuyt AM, Van Moerkercke W, Hiele M. Montelukast as a treatment modality for eosinophilic gastroenteritis. Acta Gastroenterol Belg. 2011;74. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/22319970\/."},{"key":"1854_CR22","doi-asserted-by":"publisher","unstructured":"Muller M. Clinicopathologic Findings in Eosinophilic Gastroenteritis: a German Case Series. J Genet Syndr Gene Ther. 2014;05. https:\/\/doi.org\/10.4172\/2157-7412.1000230.","DOI":"10.4172\/2157-7412.1000230"},{"key":"1854_CR23","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/S0091-6749(03)80936-3","volume":"111","author":"E Lu","year":"2003","unstructured":"Lu E, Ballas ZK. Immuno-modulation in the treatment of eosinophilic gastroenteritis. J Allergy Clin Immunol. 2003;111:S262.","journal-title":"J Allergy Clin Immunol."},{"key":"1854_CR24","doi-asserted-by":"publisher","unstructured":"Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci. 2001;46. https:\/\/doi.org\/10.1023\/a:1010682310928.","DOI":"10.1023\/a:1010682310928"},{"key":"1854_CR25","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/gut.2006.099465","volume":"55","author":"MC Urek","year":"2006","unstructured":"Urek MC, Kujund\u017ei\u0107 M, Bani\u0107 M, Urek R, Vei\u0107 T\u0160, Kardum D. Leukotriene receptor antagonists as potential steroid sparing agents in a patient with serosal eosinophilic gastroenteritis. Gut. 2006;55:1363.","journal-title":"Gut."},{"key":"1854_CR26","doi-asserted-by":"publisher","unstructured":"Menon J, Venkatesh V, Bhatia A, Rana SS, Lal SB. Ascites: an unusual presentation of eosinophilic gastroenteritis in a child. Trop Doct. 2020;50. https:\/\/doi.org\/10.1177\/0049475520911230.","DOI":"10.1177\/0049475520911230"},{"key":"1854_CR27","unstructured":"Vithayasai N, Jennuvat S, Lertsatit A. Eosinophilic gastrointestinal disease: analysis of sixteen cases from ten years experience in Thailand. J Med Assoc Thai. 2011;94 Suppl 3. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/22043753\/."},{"key":"1854_CR28","doi-asserted-by":"publisher","unstructured":"Ito J, Fujiwara T, Kojima R, Nomura I. Racial differences in eosinophilic gastrointestinal disorders among Caucasian and Asian. Allergol Int. 2015;64. https:\/\/doi.org\/10.1016\/j.alit.2015.02.003.","DOI":"10.1016\/j.alit.2015.02.003"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01854-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T10:04:28Z","timestamp":1625738668000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01854-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01854-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethics approval and consent is waived by Anne Arundel Medical Center (AAMC) Clinical Research Committee. AAMC Clinical Research Committee director: Erika Siegrist MS, RN, ACRP-CP, phone:\u2009+\u20091 (443) 4811320, e-mail: esiegrist@aahs.org.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}